Ionis Pharmaceuticals, Inc.
MODULATORS OF PNPLA3 EXPRESSION
Last updated:
Abstract:
The present embodiments provide methods, compounds, and compositions useful for inhibiting PNPLA3 expression, which may be useful for treating, preventing, or ameliorating a disease associated with PNPLA3.
Status:
Application
Type:
Utility
Filling date:
22 Jul 2020
Issue date:
18 Mar 2021